Letter to the Editor;Maladie de Fabry

Presse Medicale

Volumn 36, Issue 1 I, 2007, Pages 69-70

  Maire, Irène ^a   Belmatoug, Nadia ^a  

^a Hospitalier Edouard Herriot   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ALPHA GALACTOSIDASE;

FABRY DISEASE; FOOD AND DRUG ADMINISTRATION; LABORATORY TEST; LETTER; LIPID METABOLISM; LYSOSOME STORAGE DISEASE; PROTEOMICS; COOPERATION; HEALTH SERVICE; HUMAN;

ALPHA-GALACTOSIDASE; COOPERATIVE BEHAVIOR; FABRY DISEASE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS;

EID: 33947513097     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2006.12.013     Document Type: Letter

References (2)

1. Lidove O., Bekri S., and Andrès E. Maladie de Fabry en 2006 : une évaluation thérapeutique très limitée. Presse Med. 35 (2006) 933-935
2. Sakuraba H., Murata-Ohsawa M., Kawashima I., Tajima Y., Kotani M., Ohshima T., et al. Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice. J. Hum. Genet. 51 (2006) 180-188